[go: up one dir, main page]

ATE541469T1 - Verfahren zum modifizieren der darmflora bei tieren - Google Patents

Verfahren zum modifizieren der darmflora bei tieren

Info

Publication number
ATE541469T1
ATE541469T1 AT06846849T AT06846849T ATE541469T1 AT E541469 T1 ATE541469 T1 AT E541469T1 AT 06846849 T AT06846849 T AT 06846849T AT 06846849 T AT06846849 T AT 06846849T AT E541469 T1 ATE541469 T1 AT E541469T1
Authority
AT
Austria
Prior art keywords
animals
modifying
intestinal flora
animal
prebiotic
Prior art date
Application number
AT06846849T
Other languages
English (en)
Inventor
Christina Khoo
Original Assignee
Hills Pet Nutrition Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37951841&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE541469(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hills Pet Nutrition Inc filed Critical Hills Pet Nutrition Inc
Application granted granted Critical
Publication of ATE541469T1 publication Critical patent/ATE541469T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K10/00—Animal feeding-stuffs
    • A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
    • A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
    • A23K10/18—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions of live microorganisms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/163—Sugars; Polysaccharides
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/174—Vitamins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/179—Colouring agents, e.g. pigmenting or dyeing agents
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
    • A23L29/206—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin
    • A23L29/244—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin from corms, tubers or roots, e.g. glucomannan
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
    • A23L29/206—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin
    • A23L29/25—Exudates, e.g. gum arabic, gum acacia, gum karaya or tragacanth
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A23L33/155—Vitamins A or D
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/01—Hydrocarbons
    • A61K31/015—Hydrocarbons carbocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A90/00—Technologies having an indirect contribution to adaptation to climate change
    • Y02A90/10—Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nutrition Science (AREA)
  • Zoology (AREA)
  • Animal Husbandry (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Physiology (AREA)
  • Dispersion Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Birds (AREA)
  • Primary Health Care (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Fodder In General (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT06846849T 2005-12-29 2006-12-29 Verfahren zum modifizieren der darmflora bei tieren ATE541469T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US75480705P 2005-12-29 2005-12-29
PCT/US2006/062702 WO2007076534A1 (en) 2005-12-29 2006-12-29 Method for modifying gut flora in animals

Publications (1)

Publication Number Publication Date
ATE541469T1 true ATE541469T1 (de) 2012-02-15

Family

ID=37951841

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06846849T ATE541469T1 (de) 2005-12-29 2006-12-29 Verfahren zum modifizieren der darmflora bei tieren

Country Status (13)

Country Link
US (1) US20070178078A1 (de)
EP (1) EP1978821B2 (de)
JP (1) JP2009522311A (de)
CN (1) CN101351124B (de)
AT (1) ATE541469T1 (de)
AU (1) AU2006330421B2 (de)
BR (1) BRPI0620734A2 (de)
CA (1) CA2635038A1 (de)
DK (1) DK1978821T3 (de)
ES (1) ES2379824T3 (de)
RU (1) RU2426451C2 (de)
WO (1) WO2007076534A1 (de)
ZA (1) ZA200805413B (de)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050158294A1 (en) 2003-12-19 2005-07-21 The Procter & Gamble Company Canine probiotic Bifidobacteria pseudolongum
US8877178B2 (en) 2003-12-19 2014-11-04 The Iams Company Methods of use of probiotic bifidobacteria for companion animals
EP2261323A1 (de) 2005-05-31 2010-12-15 The Iams Company Probiotische Katzen-Laktobazillen
EP1885383B1 (de) 2005-05-31 2016-09-21 IAMS Europe B.V. Katzen probiotisches bifidobacterium
EP2124966B1 (de) 2007-02-01 2015-09-09 IAMS Europe B.V. Verfahren zur verringerung von entzündung und oxidativem stress bei einem säugetier mit glucose-antimetaboliten, avocado oder avocado-extrakten
WO2009063221A2 (en) * 2007-11-13 2009-05-22 Biotec Pharmacon Asa Methods of treating or preventing inflammatory diseases of the intestinal tract
US9771199B2 (en) * 2008-07-07 2017-09-26 Mars, Incorporated Probiotic supplement, process for making, and packaging
US9232813B2 (en) * 2008-07-07 2016-01-12 The Iams Company Probiotic supplement, process for making, and packaging
US9848760B2 (en) * 2009-06-29 2017-12-26 Gearbox, Llc Devices for continual monitoring and introduction of gastrointestinal microbes
US10104903B2 (en) 2009-07-31 2018-10-23 Mars, Incorporated Animal food and its appearance
FI122247B (fi) 2009-08-12 2011-10-31 Vetcare Oy Probioottinen valmiste koiran maha- ja suolistokanavassa ilmenevien häiriöiden ennaltaehkäisemiseksi tai hoitamiseksi
RU2414231C1 (ru) * 2009-10-21 2011-03-20 Общество С Ограниченной Ответственностью "Парафарм" Антиоксидантное средство
EP2332426A1 (de) * 2009-12-11 2011-06-15 Technische Universität Graz Präbiotikum
WO2011075138A1 (en) 2009-12-18 2011-06-23 Hill's Pet Nutrition, Inc. Pet food compositions including probiotics and methods of manufacture and use thereof
AU2011209940B2 (en) 2010-02-01 2015-08-20 Ferring Microbiome Inc. Bacteriotherapy for clostridium difficile colitis
KR102157718B1 (ko) 2010-07-26 2020-09-18 큐 바이올로직스 인코포레이티드 면역원성 소염 조성물
US9694039B2 (en) 2013-06-05 2017-07-04 Rebiotix, Inc. Microbiota restoration therapy (MRT), compositions and methods of manufacture
US9511100B2 (en) 2013-06-05 2016-12-06 Rebiotix, Inc. Microbiota restoration therapy (MRT), compositions and methods of manufacture
US9782445B2 (en) 2013-06-05 2017-10-10 Rebiotix, Inc. Microbiota restoration therapy (MRT), compositions and methods of manufacture
US9511099B2 (en) 2013-06-05 2016-12-06 Rebiotix, Inc. Microbiota restoration therapy (MRT), compositions and methods of manufacture
US10383901B2 (en) 2013-06-05 2019-08-20 Rebiotix, Inc. Microbiota restoration therapy (MRT), compositions and methods of manufacture
LT3003330T (lt) 2013-06-05 2018-10-25 Rebiotix, Inc. Mikrobiotos atstatymo terapija (mat), kompozicijos ir gamybos būdai
CN103636945A (zh) * 2013-12-06 2014-03-19 江苏威泰龙生物科技有限公司 畜禽用复合型生物活性肽制品及应用
CA2985729C (en) 2015-05-11 2023-05-09 Mybiotics Pharma Ltd Systems and methods for growing a biofilm of probiotic bacteria on solid particles for colonization of bacteria in the gut
US10799539B2 (en) 2015-06-09 2020-10-13 Rebiotix, Inc. Microbiota restoration therapy (MRT) compositions and methods of manufacture
US10828340B2 (en) 2015-06-09 2020-11-10 Rebiotix, Inc. Microbiota restoration therapy (MRT) compositions and methods of manufacture
KR102175829B1 (ko) 2015-06-09 2020-11-06 리바이오틱스, 인코퍼레이티드 미생물상 복원 치료(ｍｒｔ) 조성물 및 제조 방법
US10905726B2 (en) 2015-06-09 2021-02-02 Rebiotix, Inc. Microbiota restoration therapy (MRT) compositions and methods of manufacture
US20190014796A1 (en) * 2015-12-30 2019-01-17 Hill's Pet Nutrition, Inc. Pet Food Compositions
US10295527B2 (en) 2016-03-14 2019-05-21 Bruce Yacyshyn Process and system for predicting responders and non-responders to mesalamine treatment of ulcerative colitis
US11946927B2 (en) 2016-03-14 2024-04-02 Musidora Biotechnology Llc Process and system for identifying individuals having a high risk of inflammatory bowel disease and a method of treatment
RU2022101485A (ru) 2016-05-25 2022-04-27 Майбиотикс Фарма Лтд. Композиция и способы для микробиотной терапии
CN109689067A (zh) * 2016-07-13 2019-04-26 卡莱多生物科技有限公司 聚糖组合物和使用方法
CN110402097A (zh) 2016-12-07 2019-11-01 普罗根尼蒂公司 胃肠道检测方法、装置和系统
US10842809B2 (en) * 2016-12-16 2020-11-24 Hills Pet Nutrition, Inc. Pet food compositions
US20210401895A1 (en) 2017-03-30 2021-12-30 Progenity, Inc. Treatment of a disease of the gastrointestinal tract with live biotherapeutics
EP3716958B1 (de) * 2017-11-28 2023-10-18 Dermapharm AG Zubereitung zur behandlung von darmmikrobiom-dysbiose
FI128916B (en) 2018-02-05 2021-03-15 Vetcare Oy Health-promoting composition and method for its preparation
CN110193030A (zh) * 2019-04-29 2019-09-03 山东苏柯汉生物工程股份有限公司 一种犬用微生态制剂及其制备方法
RU2709495C1 (ru) * 2019-08-01 2019-12-18 Общество с ограниченной ответственностью "Гелеспон" Способ очищения кишечника и набор для его осуществления
CN115003172A (zh) * 2020-02-12 2022-09-02 帝斯曼知识产权资产管理有限公司 抗氧化剂至肠道的直接递送
CN116367823A (zh) * 2020-10-28 2023-06-30 帝斯曼知识产权资产管理有限公司 直接递送维生素以抑制微生物病原体

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5780451A (en) * 1994-04-01 1998-07-14 Abbott Laboratories Nutritional product for a person having ulcerative colitis
ES2218662T3 (es) * 1996-01-31 2004-11-16 South Alabama Medical Science Foundation Preparaciones de alimento y vitaminas que contienen isomeros naturales de folatos reducidos.
JP3390613B2 (ja) * 1996-10-04 2003-03-24 明治乳業株式会社 ビフィズス因子の活性増強・安定化剤
JPH10168095A (ja) † 1996-12-10 1998-06-23 Cci Corp 炎症性腸疾患予防および治療剤
US6156355A (en) * 1998-11-02 2000-12-05 Star-Kist Foods, Inc. Breed-specific canine food formulations
US20030198661A1 (en) * 2000-01-31 2003-10-23 Mars Incorporated Antioxidant compositions and methods for companion animals
NZ527924A (en) † 1999-01-29 2005-01-28 Mars Uk Ltd Antioxidant compositions and methods for companion animals
US6238708B1 (en) * 1999-02-23 2001-05-29 The Iams Company Composition and process for controlling glucose metabolism in companion animals by dietary starch
KR100796963B1 (ko) * 2000-05-25 2008-01-22 소시에떼 데 프로듀이 네슬레 소시에떼아노님 애완동물 사료용 신규 프로바이오틱
GB0027761D0 (en) † 2000-11-14 2000-12-27 Nestle Sa Nutritional composition for an immune condition
JP4853986B2 (ja) * 2001-09-20 2012-01-11 雪印メグミルク株式会社 炎症性腸疾患及び過敏性腸症候群の予防・治療剤
ITMI20020399A1 (it) * 2002-02-28 2003-08-28 Ct Sperimentale Del Latte S P Composizioni dietetiche e/o farmaceutiche per uso umano e/o animale abase di preparati microbici probiotici
WO2004000045A2 (en) † 2002-06-21 2003-12-31 Canacure Corporation Liquid compositions comprising non-digestible oligosaccharides and green tea catechins, method and uses thereof
US20050107465A1 (en) † 2003-10-01 2005-05-19 Papas Andreas M. Composition for treating inflammatory bowel disease
US7754677B2 (en) † 2003-12-05 2010-07-13 Hill's Pet Nutrition, Inc. Composition and method for reducing diarrhea in a mammal
EP1722630A4 (de) † 2004-01-20 2009-05-27 Richard F Harty Zusammensetzungen und verfahren zur behandlung von entzündungskrankheiten

Also Published As

Publication number Publication date
DK1978821T3 (da) 2012-05-14
CN101351124B (zh) 2014-09-03
BRPI0620734A2 (pt) 2012-09-18
EP1978821A1 (de) 2008-10-15
AU2006330421B2 (en) 2011-03-24
EP1978821B2 (de) 2019-02-06
CN101351124A (zh) 2009-01-21
US20070178078A1 (en) 2007-08-02
JP2009522311A (ja) 2009-06-11
RU2426451C2 (ru) 2011-08-20
ZA200805413B (en) 2013-03-27
EP1978821B1 (de) 2012-01-18
ES2379824T3 (es) 2012-05-04
CA2635038A1 (en) 2007-07-05
RU2008131072A (ru) 2010-02-10
WO2007076534A1 (en) 2007-07-05
AU2006330421A1 (en) 2007-07-05

Similar Documents

Publication Publication Date Title
ATE541469T1 (de) Verfahren zum modifizieren der darmflora bei tieren
PL1874917T3 (pl) Kompozycja probiotyczna odpowiednia dla zwierząt
ZA200803819B (en) Probiotic Enterococci for improved immunity
DK1824500T3 (da) Probiotisk lactobacillus-stamme til forbedret vaginal sundhed
DK3219328T3 (da) Humane anti-il-23-antistoffer, sammensætninger, fremgangsmåder og anvendelser
NZ602704A (en) Method of diagnostic of inflammatory bowel diseases
WO2012009712A3 (en) Methods and compositions including spore-forming bacteria for increasing the health of animals
MX2010008726A (es) Composiciones y metodos para influir en la recuperacion a partir de actividad fisica intensa.
EP3336182A3 (de) Modifizierte phosphatasen
WO2008053444A3 (en) Treating a respiratory condition with bifidobacterium
PT1940250E (pt) Método para estimular a flora intestinal
FR2930554B1 (fr) Melange elastomerique comprenant majoritairement un elastomere dienique couple par un groupe amino-alcoxysilane, composition de caoutchouc le comprenant et leurs procedes d'obtention.
IN2012DN00760A (de)
MX343120B (es) Calabaza con resistencia mejorada a la enfermedad.
DE602007006692D1 (de) Zusammensetzungen und verfahren für die gewichtskontrolle bei tieren
MX2012004118A (es) Metodos para prevenir o tratar sarcopenia y atrofia muscular en animales.
DK1624762T3 (da) Probiotisk præparat med mindst to mælkesyrebakteriestammer som er i stand til kolonisere mavetarmkanalen, i kombination med at de besidder overlevelsesegenskab, tarmbindende egenskab, en infektionsbeskyttelsesegenskab og en fiberfermenterende egenskab
DK2101796T3 (da) Bacillus smithii stamme TBM112 MSCL P737 og anvendelse af endosporer deraf som probiotikum eller kosttilskud
EP1862081A4 (de) Futtermittelzusammensetzung und verfahren zum züchten von tieren
NO20055653L (no) Forbedring av helsen og/eller naeringsstatusen hos et akvarisk dyr ved hjelp av Bacillus licheniformis
MY174494A (en) Method for inhibiting pathogens using a nutritional composition
FR2918844B1 (fr) Composition thermoresistante pour animaux comprenant un melange enzymatique
EP2140261A4 (de) Verfahren und mittel zur bewertung von entzündlicher darmkrankheit sowie ziele für die behandlung
ATE541468T1 (de) Mikrobielle futterergänzungsmittel und verwendungen davon in verfahren zur verringerung und/oder verhinderung von azidose in polygastrischen pflanzenfressern
FI20096400A0 (fi) Veriryhmästatuksen käyttö I